Antibiotic Stewardship
Global incidence in hospital-associated infections resistant to antibiotics: an analysis of point prevalence surveys from 99 countries
30 Jun, 2023 | 14:33h | UTC
WHO outlines 40 research priorities on antimicrobial resistance
26 Jun, 2023 | 00:50h | UTCNews release: WHO outlines 40 research priorities on antimicrobial resistance – World Health Organization
Report: Global research agenda for antimicrobial resistance in human health – World Health Organization
Commentary on Twitter
?WHO published its 1st global research agenda for the world’s scientists to address the most urgent human health priorities to combat antimicrobial resistance
It outlines 40 research topics on drug-resistant bacteria,fungi& Mycobacterium TB
H/t @paimadhuhttps://t.co/AOVObnJK5Q pic.twitter.com/owZJwMIDXK— Antibiotic Steward Bassam Ghanem?? (@ABsteward) June 22, 2023
RCT | High-dose dual-antibiotic cement doesn’t lower infection rates in hip hemiarthroplasty
26 Jun, 2023 | 00:47h | UTCSummary: This randomized superiority trial studied the effect of high-dose dual-antibiotic loaded cement versus standard care single-antibiotic loaded cement on deep surgical site infection (SSI) rates in hip hemiarthroplasty patients. This large-scale study, conducted in 26 UK hospitals, included people aged 60 and older with a hip fracture.
The trial randomly allocated 4936 participants to either treatment group. The primary outcome was deep SSI at 90 days post-randomisation. Notably, no significant difference was found between the groups. About 1.7% of participants in the single-antibiotic group and 1.2% in the dual-antibiotic group experienced a deep SSI (adjusted odds ratio 1.43; 95% CI 0.87–2.35; p=0.16). This result contradicts previous findings suggesting that high-dose dual-antibiotic cement could reduce infection rates.
News release: Antibiotic bone cement found not to reduce infection after hip replacement – University of Oxford
Review | Differentiating infection, colonization, and sterile inflammation in critical illness
26 Jun, 2023 | 00:41h | UTCDifferentiating infection, colonisation, and sterile inflammation in critical illness: the emerging role of host-response profiling – Intensive Care Medicine (free for a limited period)
Commentary on Twitter
Infection, colonisation, sterile inflammation in critical illness?
? current approaches to distinguishing
? host–pathogen interactions
? techniques to characterise host response
? challenges/limitations of host‑response diagnostics
#FOAMcc @yourICM
?️https://t.co/d3vhgrt3ZE pic.twitter.com/eDFiinMvSp— Intensive Care Medicine (@yourICM) June 22, 2023
Review | The antibiotic bead pouch – A useful technique for infection prevention and therapy in trauma surgery
26 Jun, 2023 | 00:35h | UTC
Review | Therapeutic drug monitoring of antimicrobials in critically ill obese patients
26 Jun, 2023 | 00:29h | UTCTherapeutic Drug Monitoring of Antimicrobials in Critically Ill Obese Patients – Antibiotics
Commentary on Twitter
?️⚡️Narrative Review @antibioticsmdpi
with @fabio_taccone
Therapeutic Drug Monitoring of Antimicrobials in Critically Ill Obese Patients #IDTwitter #CCTwitter https://t.co/s8dvWjtIwt pic.twitter.com/WWyflkblVY— Antibiotic Steward Bassam Ghanem?? (@ABsteward) June 24, 2023
Retrospective study | Increasing prevalence and severity of carbapenem-resistant Klebsiella Pneumoniae in ICUs
23 Jun, 2023 | 13:25h | UTC
Consensus Paper | Primary prophylaxis of invasive fungal diseases in patients with hematological malignancies
23 Jun, 2023 | 13:23h | UTC
Review | Early lead extraction for infected implanted cardiac electronic devices
22 Jun, 2023 | 15:03h | UTC
Review | Antifungal dosing in critically ill patients on extracorporeal membrane oxygenation
21 Jun, 2023 | 13:31h | UTC
The foot in diabetes – a reminder of an ever-present risk
21 Jun, 2023 | 13:10h | UTCThe foot in diabetes – a reminder of an ever-present risk – Clinical Medicine Journal
Related: Guideline Series | Prevention and management of diabetes-related foot disease
RCT | Continuous vs. intermittent meropenem administration shows similar mortality and drug-resistance in sepsis patients
19 Jun, 2023 | 14:11h | UTCContinuous vs Intermittent Meropenem Administration in Critically Ill Patients With Sepsis: The MERCY Randomized Clinical Trial – JAMA (free for a limited period)
Editorial: Do Prolonged Infusions of β-Lactam Antibiotics Improve Outcomes in Critically Ill Patients With Sepsis? – JAMA (free for a limited period)
See also: Visual Abstract
Commentary: Trial finds no difference between continuous, intermittent meropenem for sepsis patients – CIDRAP
Commentary on Twitter
Continuous administration of meropenem, compared with intermittent administration, does not improve clinically relevant outcomes in critically ill patients with #sepsis. https://t.co/eJ9zdGI4k2 #CCR23 pic.twitter.com/8n2eR9qBPe
— JAMA (@JAMA_current) June 16, 2023
Review | Necessity of antigen testing for Legionella in hospitalized patients with community-acquired pneumonia
19 Jun, 2023 | 13:56h | UTC
Review | Bloodstream infection and gram-negative resistance: the role for newer antibiotics
16 Jun, 2023 | 13:57h | UTCBloodstream Infection and Gram-Negative Resistance: The Role for Newer Antibiotics – Antibiotics
Review | Aminoglycosides for the treatment of severe infection due to resistant gram-negative pathogens
16 Jun, 2023 | 13:56h | UTC
Review | Antifungal stewardship interventions in patients with hematologic malignancies
16 Jun, 2023 | 13:47h | UTCAntifungal Stewardship Interventions in Patients with Hematologic Malignancies
Review | Contribution of wastewater to antimicrobial resistance
15 Jun, 2023 | 14:49h | UTCRelated studies on surveillance of wastewater:
Use of Wastewater for Mpox Outbreak Surveillance in California – New England Journal of Medicine
Opinion: Wastewater analysis can be a powerful public health tool—if it’s done sensibly.
CDC unveils its latest weapon in Covid-19 detection: wastewater.
[Preprint] Wastewater genomic testing can effectively track COVID-19 variants of concern.
Human Waste Could Be The Next Big Weapon in Controlling COVID-19 – TIME
Next steps for wastewater testing to help end this pandemic — and prevent the next one – STAT
The myriad ways sewage surveillance is helping fight COVID around the world – Nature
It’s time to begin a national wastewater testing program for Covid-19 – STAT
Coronavirus: Testing sewage an ‘easy win’ – BBC
M-A | Preoperative IV plus oral antibiotics reduce surgical site infections in elective colorectal surgery
14 Jun, 2023 | 14:31h | UTCRelated:
Commentary on Twitter
Recent network? #metaanalysis indicates that bowel prep w iv + oral antibiotics w/wo mech bowel prep results in ⤵️SSI? and anast insuff☔️ compared to other combinations in colorect?! https://t.co/pALtvscZCh#colorectalsurgery #StepUp4CRC #SoMe4Surgery @Mcfark @LauraLorenzonMD pic.twitter.com/KQSBk0NwEB
— BJS Open (@BjsOpen) June 5, 2023
Review | Challenges and opportunities in antimicrobial stewardship among hematopoietic stem cell transplant and oncology patients
13 Jun, 2023 | 13:55h | UTC
IDSA 2023 Guidance on the treatment of antimicrobial resistant gram-negative infections
12 Jun, 2023 | 13:58h | UTCRelated:
Review | Drivers of inappropriate antibiotic use in low- and middle-income countries
12 Jun, 2023 | 13:35h | UTC
AAOS Appropriate Use Criteria | Prevention of surgical site infections after major extremity trauma
7 Jun, 2023 | 13:58h | UTCRelated:
Global guidelines on the prevention of surgical site infection – World Health Organization
AAOS Guideline: Prevention of surgical site infections after major extremity trauma.
Podcast | Ascend your understanding of pelvic inflammatory disease
6 Jun, 2023 | 14:23h | UTC#83: Ascend Your Understanding of Pelvic Inflammatory Disease (PID) – The Cribsiders
RCT | Sulbactam-durlobactam non-inferior to colistin for acinetobacter baumannii-calcoaceticus complex infections
5 Jun, 2023 | 13:31h | UTCEfficacy and safety of sulbactam–durlobactam versus colistin for the treatment of patients with serious infections caused by Acinetobacter baumannii–calcoaceticus complex: a multicentre, randomised, active-controlled, phase 3, non-inferiority clinical trial (ATTACK) – The Lancet Infectious Diseases (link to abstract – $ for full-text)
News Release: Novel Antibiotic Succeeds in Trial Against Hospital-Acquired Pneumonia – Rutgers University
Quality-improvement intervention | Impact of stopping preoperative screening for asymptomatic bacteriuria
2 Jun, 2023 | 12:29h | UTCCommentary: Hospital intervention reduces unnecessary screening, antibiotics for bacteriuria – CIDRAP